Skip to main content
TipRanks
Go Ultimate75% OFF

Seed Co., Ltd. (7743) AI Stock Analysis

1 Followers
JP:7743

Seed Co., Ltd.

(TSE/TYO:7743)

Select Model
Rating:53Neutral
Price Target:JPY 798.00â–²(1.53% Upside)
Action:reiterated
Date:11/16/26

Seed Co., Ltd.'s moderate score is primarily weighed down by significant fundamental risks, notably escalating debt levels and severe cash burn, which overshadow its steady revenue growth. While the long-term technical trend remains favorable, a premium P/E valuation and overbought momentum indicators limit the stock's near-term appeal.

Positive Factors
Steady Revenue GrowthConsistent, modest revenue growth indicates ongoing demand for Seed’s ophthalmic products and provides a durable base for operations. Continued expansion across consumer retail and professional eye-care channels can support scale and give management a foundation for rebuilding profitability.
Negative Factors
Net Margin CompressionThe sharp decline in net margin shows that recent revenue growth is converting into substantially less bottom-line profit. With only modest operating profitability, Seed has limited earnings cushion against higher costs or weaker demand, making recovery dependent on restoring more durable margins.

Seed Co., Ltd. (7743) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%40%50%JP:7743+42.79%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 23.79B
Dividend Yield
1.91%
Average Volume (3M)
260.45K
Price to Earnings (P/E)
28.6
Beta (1Y)
0.47
Revenue Growth
4.13%
EPS Growth
-39.39%
Country
Japan
Employees
1,048
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Seed Co., Ltd. Business Overview & Revenue Model

Company Description

SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision en...

Seed Co., Ltd. Financial Statement Overview

Summary

Financial health is strained by deteriorating profitability and cash flow. Despite consistent revenue growth to 34.9 billion TTM, net margins have compressed to 2.38%. Heavy capital expenditures have driven free cash flow deeply negative to -6.91 billion, forcing a surge in external financing that pushed the debt-to-equity ratio to a concerning 2.05x.

Income Statement

62Positive

Balance Sheet

45Neutral

Cash Flow

38Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue34.93B33.94B33.23B32.40B30.59B28.84B
Gross Profit16.00B15.22B14.63B14.18B11.62B12.01B
EBITDA5.84B4.76B5.05B5.12B2.83B4.45B
Net Income833.49M1.14B1.09B1.96B-316.09M1.15B
Balance Sheet
Total Assets66.25B62.50B51.76B49.57B40.01B41.79B
Cash, Cash Equivalents and Short-Term Investments5.53B4.21B7.12B9.89B4.94B3.88B
Total Debt39.39B28.47B26.26B24.18B20.89B22.04B
Total Liabilities47.09B42.90B33.38B31.92B27.87B29.25B
Stockholders Equity19.16B19.27B18.06B17.36B11.86B12.26B
Cash Flow
Free Cash Flow-6.92B-438.07M-1.70B2.19B2.79B2.15B
Operating Cash Flow2.96B2.69B2.98B6.02B3.35B3.27B
Investing Cash Flow-10.63B-3.84B-4.57B-3.76B-440.73M-881.61M
Financing Cash Flow7.27B-1.91B-1.13B2.64B-1.82B-2.42B

Seed Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price786.00

Price Trends

50DMA789.24Negative
100DMA657.28Positive
200DMA600.90Positive

Market Momentum

MACD4.19Positive
RSI72.47Negative
STOCH33.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7743, the sentiment is Positive. The current price of 786.00 is above the 20-day moving average (MA) of 785.75, below the 50-day MA of 789.24, and above the 200-day MA of 600.90, indicating a neutral trend. The MACD of 4.19 indicates Positive momentum. The RSI at 72.47 is Negative, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7743.

Seed Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:7743 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:7730JP:773079OutperformJPY 147.09B20.97―2.75%10.18%55.86%
JP:5889JP:588969NeutralJPY 53.81B12.39―3.84%15.36%5.16%
JP:3046JP:304666NeutralJPY 161.75B20.8422.48%1.50%14.41%-6.42%
JP:3360JP:336055NeutralJPY 228.28B17.209.49%2.29%6.47%-3.79%
JP:7780JP:778055NeutralJPY 146.24B22.946.65%1.46%5.60%25.38%
JP:7743JP:774353NeutralJPY 23.79B28.61―1.91%4.13%-39.39%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%JP:7743JP:3046JP:7780JP:3360JP:5889JP:7730Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7743 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7743Seed Co., Ltd.786.00231.6341.78%
JP:3046JINS HOLDINGS 6930.00833.6113.67%
JP:7780Menicon Co 1922.00573.5342.53%
JP:3360Ship Healthcare Holdings 2623.0075.262.95%
JP:5889Japan Eyewear Holdings Co.,Ltd.2212.00405.5522.45%
JP:7730Mani, Inc.1493.0086.986.19%

Seed Co., Ltd. Corporate Events

Seed Reports Higher Sales and Operating Profit but Lower Net Income

Nov 9, 2026

Seed Co., Ltd. is a Tokyo Stock Exchange Standard Market-listed company; the release provides no description of its industry, primary products or market focus.For the six months ended September 30, 2026, consolidated sales rose 5.8% year on year to ¥...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 16, 2026